MCK is trading at $784.99 (5.4% up) in pre-market, rebounding from recent multi-day weakness despite broader index futures trading lower.
- No fresh company-specific news, earnings, or major regulatory actions have been reported since last week’s rating reiterations and prior commentary on medical-surgical financing.
- The move may reflect bargain hunting or positioning in healthcare distributors rather than a clearly identified new catalyst.